Determinants of glycopeptides consumption in hospitals.

Rogues, A M; Dumartin, C; Lashéras, A; Venier, A G; Fourrier, A; Parneix, P; Gachie, J P

Rogues, A M; Dumartin, C; Lashéras, A; Venier, A G; Fourrier, A; Parneix, P; Gachie, J P.

Affiliation

Rogues AM; Unité INSERM 657, Pharmacoépidémiologie et évaluation de l'impact des produits de santé sur les populations, IFR Santé Publique Université Victor Ségalen Bordeaux 2, France. anne-marie.rogues@chu-bordeaux.fr

Microb Drug Resist ; 13(3): 199-203, 2007.

Article in En | MEDLINE | ID: mdl-17949307

Subject(s)

Anti-Bacterial Agents/therapeutic use; Glycopeptides/therapeutic use; Practice Patterns, Physicians'/statistics & numerical data; Staphylococcus aureus/drug effects; Anti-Bacterial Agents/administration & dosage; Catheterization, Central Venous/adverse effects; Cross Infection/prevention & control; Drug Utilization/statistics & numerical data; France/epidemiology; Glycopeptides/administration & dosage; Hospital Bed Capacity; Hospital Units; Hospitals/statistics & numerical data; Humans; Linear Models; Methicillin Resistance; Multivariate Analysis; Practice Guidelines as Topic; Staphylococcus aureus/isolation & purification

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Staphylococcus aureus / Practice Patterns, Physicians' / Glycopeptides / Anti-Bacterial Agents Type of study: Guideline / Prognostic_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Microb Drug Resist Journal subject: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2007 Document type: Article Affiliation country: France

Search on Google

Add to My VHL

XML

PubMed Links